Trials / Completed
CompletedNCT02701374
Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia
TRK-700 An Early Phase II Study in Patients With Post-Herpetic Neuralgia -Double Blind Comparison With Placebo-
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 184 (actual)
- Sponsor
- Toray Industries, Inc · Industry
- Sex
- All
- Age
- 20 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
In Post-Herpetic Neuralgia(PHN) patients: * To conduct an explorative investigation of the efficacy and safety of repeated oral doses of TRK-700 via a randomized double blind comparative study * To measure the plasma concentration of TRK-700 and its metabolites
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TRK-700 | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2016-03-08
- Last updated
- 2017-10-25
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02701374. Inclusion in this directory is not an endorsement.